In order to determine the significance of K302 methylation in breast cancer development and evaluate the potential of SET7/9 as a biomarker or therapeutic target, the mutual impact between K302 methylation and other modifications of ERα needs to be investigated 12. The gene discussed is ESR1; the disease is breast cancer.